Board MeetingMay 28, 2026, 04:31 PM
Tarsus Pharmaceuticals to Present at Two Investor Conferences
AI Summary
Tarsus Pharmaceuticals announced its management will participate in two upcoming investor conferences: the William Blair 46th Annual Growth Stock Conference and the 2026 Jefferies Global Healthcare Conference. Live webcasts and replays of these presentations will be accessible on the company's website. Tarsus Pharmaceuticals focuses on revolutionizing treatment for patients, starting with eye care, and has an FDA-approved product, XDEMVY, for Demodex blepharitis.
Key Highlights
- Tarsus Pharmaceuticals to participate in the William Blair 46th Annual Growth Stock Conference on June 2nd at 8:00 a.m. PT / 11:00 a.m. ET.
- Tarsus Pharmaceuticals to participate in the 2026 Jefferies Global Healthcare Conference on June 3rd at 8:40 a.m. PT / 11:40 a.m. ET.
- Live webcasts and replays will be available on the Tarsus website.
Price Impact
More from TARS